Search

everythinglearnresearchcommunity

for

Search:↓

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

JAK inhibitors are effective treatments for alopecia areata.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Rituximab can cause skin issues, but baricitinib may help improve them.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

BOOST is a promising, easy-to-use treatment for diabetic foot ulcers that improves healing by reducing inflammation and promoting blood vessel growth.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Pulsed electric field treatment may help the immune system fight liver tumors.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

Two men experienced hair regrowth while being treated with immune globulin for other health issues, but there were also side effects.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Cyclosporin is effective in treating dog skin diseases and has fewer side effects compared to other treatments.

miR-486 may help prevent hair loss in alopecia areata.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Targeting mitophagy may help treat alopecia areata by reducing inflammasome activation.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.